Votrient
$1,902.00 – $3,569.00
Votrient is used in treating adults as the first line treatment of advanced Renal Cell Carcinoma
Renal cell carcinoma (RCC)Votrient is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.Soft tissue sarcoma (STS)Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
Brand Manufacturer:
Reviews
Write a review
The product has no reviews
Leave your review
